Home LiteratureArticle Details
PMID: 8551619 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains.

Journal of virology ·Vol. 70 ·No. 2 ·1996-02-00 ·Pages 809-19

Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K

Abstract

The human immunodeficiency virus type 1 (HIV-1) Vpu protein is an integral membrane phosphoprotein that induces CD4 degradation in the endoplasmic reticulum and enhances virus release from the cell surface. CD4 degradation is specific, requires phosphorylation of Vpu, and involves the interaction between Vpu and the CD4 cytoplasmic domain. In contrast, regulation of virus release is less specific and not restricted to HIV-1 and may be mechanistically-distinct from CD4 degradation. We show here that a mutant of Vpu, Vpu35, lacking most of its cytoplasmic domain has residual biological activity for virus release but is unable to induce CD4 degradation. This finding suggests that the N terminus of Vpu encoding the transmembrane (TM) anchor represents an active domain important for the regulation of virus release but not CD4 degradation. To better define the functions of Vpu's TM anchor and cytoplasmic domain, we designed a mutant, VpuRD, containing a scrambled TM sequence with a conserved amino acid composition and alpha-helical structure. The resulting protein was integrated normally into membranes, was able to form homo-oligomers, and exhibited expression levels, protein stability, and subcellular localization similar to those of wild-type Vpu. Moreover, VpuRD was capable of binding to CD4 and to induce CD4 degradation with wild-type efficiency, confirming proper membrane topology and indicating that the alteration of the Vpu TM domain did not interfere with this function of Vpu. However, VpuRD was unable to enhance the release of virus particles from infected or transfected cells, and virus encoding VpuRD had replication characteristics in T cells indistinguishable from those of a Vpu-deficient HIV-1 isolate. Mutation of the phosphorylation sites in VpuRD resulted in a protein which was unable to perform either function of Vpu. The results of our experiments suggest that the two biological activities of Vpu operate via two distinct molecular mechanisms and involve two different structural domains of the Vpu protein.

MeSH Terms
Amino Acid Sequence Animals Binding Sites CD4 Antigens/metabolism HIV Seropositivity/blood,immunology HIV-1/isolation & purification,metabolism HeLa Cells Human Immunodeficiency Virus Proteins Humans Membrane Proteins/chemistry,genetics,metabolism Molecular Sequence Data Mutagenesis, Site-Directed Viral Regulatory and Accessory Proteins/chemistry,genetics,metabolism Virion/metabolism
Chemicals
CD4 Antigens Human Immunodeficiency Virus Proteins Membrane Proteins Viral Regulatory and Accessory Proteins vpu protein, Human immunodeficiency virus 1
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Schubert U
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892-0460, USA.
Bour S
Ferrer-Montiel A V
Montal M
Maldarell F
Strebel K
References (37)
37 references, click to expand
  1. The effect of vpu on HIV-1-induced syncytia formation.
    J Acquir Immune Defic Syndr. 1993 Feb;6(2):135-41 PMID: 8094456
  2. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity.
    J Virol. 1993 Jul;67(7):3877-84 PMID: 8510209
  3. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein.
    J Virol. 1993 Aug;67(8):5056-61 PMID: 8331740
  4. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses.
    Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7381-5 PMID: 8346259
  5. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
    J Virol. 1993 Sep;67(9):5538-49 PMID: 8350411
  6. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.
    J Virol. 1993 Dec;67(12):7238-45 PMID: 8230446
  7. Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein.
    J Virol. 1994 Feb;68(2):1207-12 PMID: 8289353
  8. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
    J Mol Biol. 1994 Feb 11;236(1):16-25 PMID: 8107101
  9. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments.
    J Virol. 1994 Apr;68(4):2260-71 PMID: 8139011
  10. The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef.
    J Virol. 1994 May;68(5):3092-101 PMID: 8151774
  11. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.
    J Virol. 1995 Mar;69(3):1510-20 PMID: 7853484
  12. Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy.
    Int J Pept Protein Res. 1995 Jan;45(1):35-43 PMID: 7775007
  13. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.
    J Virol. 1995 Dec;69(12):7699-711 PMID: 7494279
  14. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):10-22 PMID: 8548340
  15. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Nature. 1988 Jan 7;331(6151):82-4 PMID: 3257544
  16. Identification of a protein encoded by the vpu gene of HIV-1.
    Nature. 1988 Aug 11;334(6182):532-4 PMID: 3043230
  17. A novel gene of HIV-1, vpu, and its 16-kilodalton product.
    Science. 1988 Sep 2;241(4870):1221-3 PMID: 3261888
  18. Functional role of human immunodeficiency virus type 1 vpu.
    Proc Natl Acad Sci U S A. 1989 Jul;86(13):5163-7 PMID: 2472639
  19. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.
    J Virol. 1989 Sep;63(9):3784-91 PMID: 2788224
  20. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.
    J Virol. 1990 Feb;64(2):621-9 PMID: 2404139
  21. Genetic organization of a chimpanzee lentivirus related to HIV-1.
    Nature. 1990 May 24;345(6273):356-9 PMID: 2188136
  22. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.
    Nature. 1990 Jun 14;345(6276):625-8 PMID: 2190096
  23. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.
    J Virol. 1990 Nov;64(11):5585-93 PMID: 2214026
  24. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
    J Virol. 1990 Dec;64(12):6297-304 PMID: 2243395
  25. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
    J Virol. 1991 Dec;65(12):6387-96 PMID: 1942241
  26. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
    J Virol. 1992 Jan;66(1):226-34 PMID: 1727486
  27. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II.
    Eur J Biochem. 1992 Mar 1;204(2):875-83 PMID: 1541298
  28. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export.
    J Virol. 1992 Aug;66(8):5119-26 PMID: 1629967
  29. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.
    J Virol. 1992 Dec;66(12):7193-200 PMID: 1433512
  30. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  31. A new technique for the assay of infectivity of human adenovirus 5 DNA.
    Virology. 1973 Apr;52(2):456-67 PMID: 4705382
  32. Cultivation and characterization of BALB-cfC3H mammary tumor cell lines.
    J Natl Cancer Inst. 1973 Dec;51(6):1849-60 PMID: 4358145
  33. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
    Proc Natl Acad Sci U S A. 1982 Nov;79(22):6777-81 PMID: 6294651
  34. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.
    Proc Natl Acad Sci U S A. 1985 Jul;82(13):4539-43 PMID: 2989831
  35. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  36. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.
    Science. 1986 Nov 28;234(4780):1123-7 PMID: 3095925
  37. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
    J Virol. 1988 Jan;62(1):139-47 PMID: 3257102
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-02-00
Pages
809-19
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC189883
Subset
IM
Grants
NIGMS NIH HHS · GM-49711 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com